Chi; Kwan-Hwa

Patent Applications and Registrations

Patent applications and USPTO patent grants for Chi; Kwan-Hwa.The latest application filed is for "use of metformin and sodium butyrate for treating conditions induced by chronic inflammation".

Company Profile

4.6.12

Chi; Kwan-Hwa - Taipei TW
CHI; Kwan-Hwa - Taipei City TW
Chi; Kwan-Hwa - Taoyuan County TW
Chi; Kwan-Hwa - New Taipei City TW

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Use of metformin and sodium butyrate for treating conditions induced by chronic inflammation Grant 11,382,878 - Chi , et al. July 12, 2	2022-07-12
Use of mTOR inhibitor and chloroquine for treating cancer Grant 11,285,143 - Chi , et al. March 29, 2	2022-03-29
Use Of Metformin And Sodium Butyrate For Treating Conditions Induced By Chronic Inflammation App 20210015769 - CHI; Kwan-Hwa ; et al.	2021-01-21
Pharmaceutical Kit And Uses Thereof App 20200163995 - CHI; Kwan-Hwa ; et al.	2020-05-28
Use Of Mtor Inhibitor And Chloroquine For Treating Cancer App 20200009127 - CHI; Kwan-Hwa ; et al.	2020-01-09
Method For Treating Tumor App 20190183798 - CHI; Kwan-Hwa ; et al.	2019-06-20
Radiolabeled active targeting pharmaceutical composition and the use thereof Grant 10,117,956 - Wang , et al. November 6, 2	2018-11-06
Radiolabeled Active Targeting Pharmaceutical Composition And The Use Thereof App 20180117188 - WANG; Hsin-Ell ; et al.	2018-05-03
Method for applying metformin and sodium butyrate in K-ras mutation cancer treatment Grant 9,913,816 - Chi , et al. March 13, 2	2018-03-13
Radiolabeled active targeting pharmaceutical composition and the use thereof Grant 9,789,214 - Wang , et al. October 17, 2	2017-10-17
Methods And Formulation For Improving Oral Availability Of Cpt-11 While Reducing Cpt-11 Induced Gastrointestinal Toxicity In Cancer Therapy App 20170246190 - LIAO; Pei-Ru ; et al.	2017-08-31
Method For Applying Metformin And Sodium Butyrate In K-ras Mutation Cancer Treatment App 20170071887 - CHI; Kwan-Hwa ; et al.	2017-03-16
Pharmaceutical composition and kit for applying metformin and sodium butyrate in Kras mutation cancer treatment Grant 9,532,960 - Chi , et al. January 3, 2	2017-01-03
Radiolabeled Active Targeting Pharmaceutical Composition And The Use Thereof App 20150231285 - WANG; Hsin-Ell ; et al.	2015-08-20
Method For Treating Epidermoid Carcinoma App 20150209364 - Wang; Yu-Shan ; et al.	2015-07-30
Method, Pharmaceutical Composition And Kit For Applying Metformin And Sodium Butyrate In Kras Mutation Cancer Treatment App 20140343144 - CHI; Kwan-Hwa ; et al.	2014-11-20
Composition Used for Thermotherapy and Producing Method Thereof and Method to Treat Cancer App 20130337043 - CHI; Kwan-Hwa ; et al.	2013-12-19
Assisting Method And Apparatus For Radiotherapy App 20100274151 - CHI; Kwan-Hwa ; et al.	2010-10-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.